Related Experiment Video
Updated: Oct 9, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human
Rende Ning1, Guang Chen2, Run Fang2
1Department of Orthopaedics, The Third Affiliated Hospital of Anhui Medical University, 390 Huaihe Road, Hefei, 230031, China. nrd192@qq.com.
Background:
Diosmetin is a bioflavonoid compound naturally abundant in citrus fruits. It is found to perform a variety of activities, while its antitumor property in osteosarcoma, a malignant tumor with unmet clinical treatment, remained unknown.
Methods:
Colony formation assay, cell cycle analysis and apoptosis analysis were conducted respectively to observe the effect of diosmetin on cell proliferation and apoptosis in human osteosarcoma cells. Western blot and immunoprecipitation were used to detect the expression of apoptotic molecules and activation of STAT3/c-Myc pathway in Saos-2 and U2SO cells.
Results:
Diosmetin significantly inhibited cell proliferation, induced cell cycle arrest at G2/M phase and promoted cell apoptosis in both Saos-2 and U2SO cells. Moreover, Diosmetin downregulated the expression of anti-apoptotic protein Bcl-xL while upregulated the levels of pro-apoptotic proteins including cleaved Caspase-3, cleaved-PARP and Bax. Furthermore, diosmetin dose-dependently inhibited STAT3 phosphorylation, reduced the expression of its downstream protein c-Myc and impeded the interaction between STAT3 molecules.
Conclusions:
These results suggest that diosmetin exerts anti-osteosarcoma effects by suppressing cell proliferation and inducing apoptosis via inhibiting the activation of STAT3/c-Myc signaling pathway, which provide the possibility for diosmetin to be a chemotherapeutic candidate for osteosarcoma.
Insights
Diosmetin, a citrus bioflavonoid, effectively inhibits osteosarcoma cell growth and promotes apoptosis. It achieves this by suppressing the STAT3/c-Myc signaling pathway, offering potential as a new cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Diosmetin is a naturally occurring bioflavonoid found in citrus fruits.
- Its potential antitumor effects, particularly in osteosarcoma, were previously unexplored.
Purpose of the Study:
- To investigate the antitumor properties of diosmetin in human osteosarcoma cells.
- To elucidate the underlying molecular mechanisms, including its effect on cell proliferation, apoptosis, and the STAT3/c-Myc pathway.
Main Methods:
- Cell proliferation and apoptosis assays (colony formation, cell cycle, apoptosis analysis).
- Western blot and immunoprecipitation to analyze protein expression and pathway activation.
- Experiments conducted on Saos-2 and U2SO human osteosarcoma cell lines.
Main Results:
- Diosmetin significantly inhibited osteosarcoma cell proliferation and induced apoptosis.
- It caused cell cycle arrest at the G2/M phase.
- Diosmetin downregulated anti-apoptotic proteins (Bcl-xL) and upregulated pro-apoptotic proteins (cleaved Caspase-3, cleaved-PARP, Bax).
- It inhibited STAT3 phosphorylation, reduced c-Myc expression, and disrupted STAT3 molecular interactions.
Conclusions:
- Diosmetin exhibits significant anti-osteosarcoma effects.
- These effects are mediated by the suppression of cell proliferation and induction of apoptosis.
- Inhibition of the STAT3/c-Myc signaling pathway is a key mechanism.
- Diosmetin shows promise as a potential chemotherapeutic agent for osteosarcoma.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
Replicative Cell Senescence